Fredun Pharmaceuticals has informed that it enclosed press release titled ‘FREDUN PHARMACEUTICALS ON A GROWTH OVERDRIVE: NET PROFIT SOARS 94%, EBITDA ROCKETS 92% AND REVENUE SURGES 87% IN H1 FY27’.
The above information is a part of company’s filings submitted to BSE.